{
    "Trade/Device Name(s)": [
        "LYHER\u00ae Urine Multi-Drug Test Kit (Cup)",
        "LYHER\u00ae Urine Multi-Drug Test Kit (Cassette)",
        "LYHER\u00ae Urine Multi-Drug Test Kit (Dipcard)"
    ],
    "Submitter Information": "Hangzhou Laihe Biotech Co., Ltd.",
    "510(k) Number": "K232597",
    "Predicate Device Reference 510(k) Number(s)": [
        "K182123"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "DIO",
        "DKZ",
        "LDJ",
        "DJC",
        "LCM"
    ],
    "Summary Letter Date": "November 27, 2023",
    "Summary Letter Received Date": "December 1, 2023",
    "Submission Date": "December 29, 2023",
    "Regulation Number(s)": [
        "21 CFR 862.3650",
        "21 CFR 862.3250",
        "21 CFR 862.3100",
        "21 CFR 862.3870",
        "21 CFR 862.3610"
    ],
    "Regulation Name(s)": [
        "Opiate test system",
        "Cocaine and cocaine metabolite test system",
        "Amphetamine test system",
        "Cannabinoid test system",
        "Methamphetamine test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine (AMP)",
        "Cocaine (COC)",
        "Marijuana (THC)",
        "Methamphetamine (MET)",
        "Opiates (OPI)",
        "Phencyclidine (PCP)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Cup",
        "Cassette",
        "Dipcard"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunochromatographic assay",
        "Competitive binding"
    ],
    "Methodologies": [
        "Qualitative drug screening",
        "Immunochromatography"
    ],
    "Submission Type(s)": [
        "Kit",
        "Panel",
        "Cassette",
        "Cup",
        "Dipcard"
    ],
    "Document Summary": "FDA 510(k) summary for LYHER Urine Multi-Drug Test Kit (Cup, Cassette, Dipcard) for qualitative detection of drugs of abuse in human urine using lateral flow immunoassay.",
    "Indications for Use Summary": "Rapid lateral flow immunoassay for qualitative detection of amphetamine, methamphetamine, benzoylecgonine, morphine, phencyclidine, and THC-COOH in human urine for prescription use only; provides preliminary results requiring confirmatory chemical testing.",
    "fda_folder": "Toxicology"
}